2020-09-24

The second pharmaceutical company to set foot in sauce and wine after Guotai, revise the group or invest in Renhuai

By yqqlm yqqlm

China.com Liquor Industry News, September 23. Yesterday, according to a report from the Rong Media Center of Renhuai City, a symposium on revising the investment projects of the Liquor Industry Group was held in Renhuai City. Wang Nengke, deputy secretary of the listing committee and mayor of the meeting, said in a speech that he hopes to revise the wine industry to give play to the advantages of large enterprises, take the route of merger and reorganization, and absorb and build a professional sauce-flavored wine production team. The next step of the amendment group may be to enter the sauce and wine, that is, after Tianlish, the second pharmaceutical group to enter the sauce and wine industry. In response to this, China.com Liquor Industry and Telecommunications Union revised the liquor industry, and no one answered the phone as of press time.

According to the official website of Zhenghua Pharmaceutical, Zhejiang Liquor is part of the Zhejiang Group and was formally established in January 2019 . According to the brief introduction, Amendment Liquor currently has its own ability to produce liquor and canned liquor, with five major liquor categories including liquor, beer, red wine, rice wine, and beverages, with a total product plan of more than 2,400. It has successively launched two major brand series products,”Xiaoliangfang” and”Xiaoliangliang”. In addition, the Amendment Liquor Group has reached strategic cooperation with the well-known enterprises in the liquor industry in Luzhou and Maotai, Wuliangye Group, and Moutai Group. Through a strong alliance, we developed and launched two series of products,”Xiang Guo Ding” and”Xiang Jian Jiang”.

getInterUrl?uicrIvZQ=a197a233cf5f5f183c330e0938268f39 - The second pharmaceutical company to set foot in sauce and wine after Guotai, revise the group or invest in Renhuai

China.com’s wine industry searched Jingdong to revise the flagship liquor store and showed that there are currently more than a dozen categories on sale, priced at around 9-20 yuan, including beer, ginseng wine, deer whip wine and other categories .

It is also mentioned in the introduction that the concept of amending the wine industry is”light luxury and health preservation”, which is known as marching into China’s health wine industry. According to the statistics of the China Liquor Industry Association, the current market for”healthy” and”health care” liquors is relatively small. Jinjiu is the industry leader, and Wuliangye, Moutai and other liquor products are in the second echelon, with a market size of about 1 billion. ; Yedao Lugui Wine, Changyu Sanbian Wine, Zhuyeqing, Ningxia Red and other brands are in the third echelon, with a market size of 1-5 The revenue of most SMEs is maintained at around 10 million. Therefore, to revise the liquor industry or aim at the current hot sauce and wine market, the sauce fragrant craze represented by Moutai is still continuing, and capital is constantly pouring into the core production areas of sauce.

According to public information, Huaxian Pharmaceutical Group Co., Ltd. (referred to as”Xiu Laigui”) was founded by Chairman Xiu Laigui in May 1995 and is one of the largest pharmaceutical companies in China. Concentrate the research, production and marketing of patent medicine, chemical pharmacy, biopharmaceutical, drug chain management, and standard cultivation of Chinese medicinal materials. Among the top 100 Chinese pharmaceutical industry companies in 2018, Amendment Pharmaceutical Group ranked third. In the selection of the top 500 Chinese brands in 2019, Amendment Pharmaceutical Group ranked second in the pharmaceutical industry with a value of 133.844 billion yuan. In the same year, its revenue reached 62.418 billion.

According to the Tianyan Check, among the shareholders of Amendment Pharmaceutical Group, Tonghua Amendment Industry Co., Ltd. holds 35 million shares, accounting for 70%. Secondly, its current chairman Xiu Laigui, holding 14.76 million shares, accounting for 29.518%. The two together hold up to 99.518%of the shares in the Amendment Pharmaceutical Group. The actual controller, Xiu Laigui, holds 98%of the shares of Tonghua Xianyang Industrial Co., Ltd. The full name of Jiaxing Liquor is Jilin Jiaxing Liquor Group Co., Ltd. It is 100%controlled by Tonghua Jiaxing Industrial Co., Ltd. In addition, Tonghua Xianhua Industry Co., Ltd. also has other subsidiaries such as real estate and hotels.

Before, there have been repeated news of the revision of the pharmaceutical industry’s listing. On July 24, 2020, the revision of the pharmaceutical industry’s backdoor Kyrgyzstan Pharmaceutical Holdings failed to list.

The same pharmaceutical companies are entering the sauce and wine industry, and the other pair of”CPs” have been in a tacit understanding for a long time. On May 22, 2020, Guizhou Guotai Liquor Industry Co., Ltd. (referred to as”Guotai”) issued the”Initial Public Offering Prospectus (Declaration Draft)” and plans to list on the Shanghai Stock Exchange. Statistics show that Guotai Liquor has a registered capital of 365 million yuan, and the controlling shareholder Tasly holds 79.02%of the equity.

Tasly, the full name of Tianjin Tasly Pharmaceutical Co., Ltd., is a high-tech enterprise group focusing on the health industry and the pharmaceutical industry, including modern Chinese medicine, chemical medicine, and biopharmaceuticals. In 2019, the company’s total operating income was 19 billion, a year-on-year increase of 5.6%; net profit attributable to the parent was 1 billion, a year-on-year decrease of 35.2%. Among them, Guotai Wine Industry contributed 1.888 billion yuan in revenue and 374 million yuan in net profit.